Hartleb M - Search Results

1

Insulin resistance and its consequences in chronic hepatitis C.

Kukla M, Piotrowski D, Waluga M, Hartleb M. Kukla M, et al. Among authors: hartleb m. Clin Exp Hepatol. 2015 May;1(1):17-29. doi: 10.5114/ceh.2015.51375. Epub 2015 Apr 30. Clin Exp Hepatol. 2015. PMID: 28856251 Free PMC article. Review.

2

The theophylline disposition after caffeine administration in liver cirrhosis: an index of liver function.

Hartleb M, Romańczyk T, Becker A, Mańczyk I, Waluga M, Spalińska M, Zieliński M. Hartleb M, et al. Ital J Gastroenterol. 1992 Jul-Aug;24(6):332-7. Ital J Gastroenterol. 1992. PMID: 1515659

3

Cardiovascular status after postural change in compensated cirrhosis: an argument for vasodilatory concept.

Hartleb M, Rudzki K, Karpel E, Becker A, Waluga M, Boldys H, Nowak A, Nowak S. Hartleb M, et al. Liver. 1997 Feb;17(1):1-6. doi: 10.1111/j.1600-0676.1997.tb00770.x. Liver. 1997. PMID: 9062872

4

Cardiovascular changes after treatment with dexfenfluramine and yohimbine in obese women measured by thoracic electrical bioimpedance.

Waluga M, Janusz M, Karpel E, Hartleb M, Nowak A. Waluga M, et al. Among authors: hartleb m. Boll Chim Farm. 1999 Jul-Aug;138(7):359-63. Boll Chim Farm. 1999. PMID: 10597657 Clinical Trial.

5

Usefulness of thoracic electrical bioimpedance in detection of ejection fraction changes.

Hartleb M, Rudzki K, Waluga M, Janusz M, Karpel E. Hartleb M, et al. J Physiol Pharmacol. 2000 Mar;51(1):151-9. J Physiol Pharmacol. 2000. PMID: 10768858 Free article.

6

[Alcoholic liver disease].

Waluga M, Hartleb M. Waluga M, et al. Among authors: hartleb m. Wiad Lek. 2003;56(1-2):61-70. Wiad Lek. 2003. PMID: 12901271 Review. Polish.

7

Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.

Hartleb M, Wandzel P, Waluga M, Matyszczyk B, Bołdys H, Romañczyk T. Hartleb M, et al. Acta Gastroenterol Belg. 2004 Oct-Dec;67(4):320-6. Acta Gastroenterol Belg. 2004. PMID: 15727075

8

Serum chemerin and vaspin in non-alcoholic fatty liver disease.

Kukla M, Zwirska-Korczala K, Hartleb M, Waluga M, Chwist A, Kajor M, Ciupinska-Kajor M, Berdowska A, Wozniak-Grygiel E, Buldak R. Kukla M, et al. Among authors: hartleb m. Scand J Gastroenterol. 2010;45(2):235-42. doi: 10.3109/00365520903443852. Scand J Gastroenterol. 2010. PMID: 20095887

9

Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.

Kukla M, Ciupińska-Kajor M, Kajor M, Wyleżoł M, Żwirska-Korczala K, Hartleb M, Berdowska A, Mazur W. Kukla M, et al. Among authors: hartleb m. Pol J Pathol. 2010;61(3):147-53. Pol J Pathol. 2010. PMID: 21225497 Free article.

10

Serum vaspin may be a good indicator of fibrosis in chronic hepatitis C and is not altered by antiviral therapy.

Kukla M, Waluga M, Sawczyn T, Berdowska A, Kajor M, Boryczka G, Stygar D, Gabriel A, Zwirska-Korczala K, Hartleb M. Kukla M, et al. Among authors: hartleb m. Pol J Pathol. 2012 Dec;63(4):213-20. doi: 10.5114/pjp.2012.32767. Pol J Pathol. 2012. PMID: 23359189 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page